Market Overview

Benzinga's Top Upgrades, Downgrades For June 28, 2018

Share:

Top Upgrades

  • Analysts at Benchmark upgraded Progress Software Corporation (NASDAQ: PRGS) from Sell to Hold. Progress Software shares rose 4.91 percent to $36.51 in pre-market trading.
  • Wells Fargo upgraded T-Mobile Us Inc (NASDAQ: TMUS) from Market Perform to Outperform. T-Mobile US shares rose 0.54 percent to $59.66 in pre-market trading.
  • BMO Capital upgraded Vale S.A. (NYSE: VALE) from Market Perform to Outperform. Vale shares rose 1.64 percent to $12.67 in pre-market trading.
  • Scotiabank upgraded CF Industries Holdings, Inc. (NYSE: CF) from Sector Perform to Sector Outperform. CF Industries shares fell 0.63 percent to close at $43.82 on Wednesday.
  • Keefe Bruyette & Woods upgraded Flagstar Bancorp, Inc. (NYSE: FBC) from Market Perform to Outperform. Flagstar Bancorp shares fell 1.52 percent to close at $34.35 on Wednesday.
  • Argus upgraded Twilio Inc (NYSE: TWLO) from Hold to Buy. Twilio shares rose 1.58 percent to $55.16 in pre-market trading.
  • Wedbush upgraded BOK Financial Corporation (NASDAQ: BOKF) from Neutral to Outperform. BOK Financial shares rose 1.98 percent to $94.86 in pre-market trading.
  • Citigroup upgraded Talend SA ADR (NASDAQ: TLND) from Neutral to Buy. Talend shares fell 3.55 percent to close at $56.20 on Wednesday.
  • Stifel Nicolaus upgraded Surgery Partners Inc (NASDAQ: SGRY) from Sell to Hold. Surgery Partners shares fell 2.23 percent to close at $15.35 on Wednesday.
  • Jefferies upgraded Madison Square Garden Co (NYSE: MSG) from Hold to Buy. Madison Square Garden shares gained 10 percent to $292.90 in pre-market trading.

Top Downgrades

  • BMO Capital downgraded Pinnacle Foods (NYSE: PF) from Outperform to Market Perform. Pinnacle Foods shares closed at $64.95 on Tuesday.
  • DA Davidson downgraded Mattel, Inc. (NASDAQ: MAT) from Neutral to Underperform. Mattel shares fell 2.86 percent to $16.30 in pre-market trading.
  • Canaccord Genuity downgraded Aquinox Pharmaceuticals Inc (NASDAQ: AQXP) from Buy to Hold. Aquinox Pharmaceuticals shares fell 2.13 percent to $2.29 in pre-market trading.
  • Stifel Nicolaus downgraded AeroVironment, Inc. (NASDAQ: AVAV) from Buy to Hold. AeroVironment shares fell 2.61 percent to $64.89 in pre-market trading.
  • Stephens & Co. downgraded Green Plains Inc (NASDAQ: GPRE) from Overweight to Equal-Weight. Green Plains shares fell 3.74 percent to close at $19.30 on Tuesday.
  • Janney Capital downgraded Summit Therapeutics (NASDAQ: SMMT) from Buy to Neutral. Summit Therapeutics shares fell 3.53 percent to $2.46 in pre-market trading.
  • BTIG Research downgraded Transenterix Inc (NYSE: TRXC) from Buy to Neutral. TransEnterix shares dropped 8.39 percent to $5.35 in pre-market trading.
  • Needham downgraded Aquinox Pharmaceuticals Inc (NASDAQ: AQXP) from Buy to Hold. Aquinox Pharmaceuticals shares fell 2.13 percent to $2.29 in pre-market trading.

Top Initiations

  • Analysts at Raymond James initiated coverage on Intercept Pharmaceuticals Inc (NASDAQ: ICPT) with a Strong Buy rating. The price target for Intercept Pharmaceuticals is set to $122. Intercept Pharmaceuticals shares closed at $78.78 on Wednesday.
  • CL King initiated coverage on Welbilt Inc (NYSE: WBT) with a Neutral rating. Welbilt shares closed at $22.14 on Wednesday.
  • Analysts at Raymond James initiated coverage on Gilead Sciences, Inc. (NASDAQ: GILD) with a Strong Buy rating. The price target for Gilead Sciences is set to $93. Gilead Sciences shares closed at $68.64 on Wednesday.
  • B. Riley FBR initiated coverage on Spark Therapeutics Inc (NASDAQ: ONCE) with a Neutral rating. The price target for Spark Therapeutics is set to $74. Spark Therapeutics shares closed at $82.87 on Wednesday.
  • Evercore ISI Group initiated coverage on Installed Building Products, Inc. (NYSE: IBP) with an In-Line rating. The price target for Installed Building Products is set to $65. Installed Building Products shares closed at $58.60 on Wednesday.
  • Imperial Capital initiated coverage on The Walt Disney Company (NYSE: DIS) with an In-Line rating. The price target for Disney is set to $108. Disney shares closed at $103.96 on Wednesday.
  • Citigroup initiated coverage on Teradata Corporation (NYSE: TDC) with a Neutral rating. The price target for Teradata is set to $42. Teradata shares closed at $39.55 on Wednesday.
  • Analysts at Benchmark initiated coverage on Flexion Therapeutics, Inc. (NASDAQ: FLXN) with a Buy rating. The price target for Flexion Therapeutics is set to $39. Flexion Therapeutics closed at $24.92 on Wednesday.
  • H.C. Wainwright initiated coverage on Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) with a Buy rating. The price target for Keryx Biopharmaceuticals is set to $9. Keryx Biopharmaceuticals closed at $4.48 on Wednesday.
  • Analysts at Nomura initiated coverage on International Business Machines Corporation (NYSE: IBM) with a Buy rating. The price target for IBM is set to $160. IBM closed at $137.48 on Wednesday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (AVAV + AQXP)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
BIIBCantor FitzgeraldDowngrades0.0
WEXSunTrust Robinson HumphreyMaintains215.0
GISCredit SuisseMaintains52.0
OWells FargoMaintains78.0
HASWells FargoMaintains82.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Imperial Capital Takes Neutral Stance On Disney, Tackles Pros, Cons Of A Twenty-First Century Fox Deal

The Market In 5 Minutes: Anthony Kennedy, Chipotle, 'Raw,' Smackdown' And More